文献速递创伤与烧伤重症综合管理与镇静镇痛

MG53治疗减轻创伤性脑损伤相关急性肾损伤

Treatment with MG53 ameliorates traumatic brain injury-associated acute kidney injury.
PubMed 文献 · J Trauma Acute Care Surg · 2025-06-12
一句话结论在雌性约克夏猪创伤性脑损伤模型中,MG53蛋白治疗可减轻血肌酐和血浆NGAL升高并保护近端肾小管上皮细胞,提示可能通过内皮细胞功能障碍机制保护远隔器官。

该研究建立创伤性脑损伤后多器官功能障碍的大动物模型,将雌性约克夏猪(每组n=5)随机分为MG53蛋白治疗组和生理盐水对照组。对照组伤后6小时血肌酐较基线显著升高(P=0.007),MG53组该升高减轻(P=0.089);对照组伤后4小时起血浆NGAL较基线显著升高(P=0.014),MG53组血清NGAL较基线无变化(P=0.163)。组织学显示MG53组近端肾小管上皮细胞损伤受到保护。结论认为创伤性脑损伤可诱导远隔器官损伤,可能通过内皮细胞功能障碍,MG53治疗可保护此损伤。

要点

  • 雌性约克夏猪创伤性脑损伤模型中,对照组伤后6小时血肌酐较基线显著升高(P=0.007),MG53组该升高减轻(P=0.089)。
  • 对照组伤后4小时起血浆NGAL较基线显著升高(P=0.014),MG53组血清NGAL较基线无变化(P=0.163)。
  • 组织学分析显示MG53治疗组近端肾小管上皮细胞损伤受到保护。
  • 蛋白变体数据显示载脂蛋白1、纤维蛋白原β和骨钙素差异表达。
  • 作者认为创伤性脑损伤可诱导远隔器官损伤,可能通过内皮细胞功能障碍,MG53可保护此损伤。

适用人群与场景

  • 雌性约克夏猪,接受控制性皮层撞击创伤性脑损伤模型,随机接受MG53蛋白治疗或生理盐水对照(每组n=5)。

研究设计与关键结果

  • 研究类型:大动物实验,雌性约克夏猪(n=5/组)接受控制性皮层撞击创伤性脑损伤后随机接受MG53蛋白治疗或生理盐水对照。
  • 主要终点结果:对照组血肌酐较基线在伤后6小时显著升高(P=0.007),MG53组该升高减轻(P=0.089)。
  • 关键次要终点:对照组血浆NGAL较基线从4小时起显著升高(P=0.014),MG53组血清NGAL较基线无变化(P=0.163);组织学显示MG53组近端肾小管上皮细胞损伤受到保护;蛋白变体数据显示载脂蛋白1、纤维蛋白原β和骨钙素差异表达。

证据类型、等级与局限

  • 证据类型:动物实验(雌性约克夏猪创伤性脑损伤模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为创伤性脑损伤可诱导远隔器官损伤,可能通过内皮细胞功能障碍,MG53治疗可保护此损伤。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Multiorgan dysfunction (MOD) after traumatic brain injury (TBI) results in increased morbidity and mortality. There is emerging evidence demonstrating TBI-induced inflammatory responses; however, the mechanisms driving TBI-induced organ injury remains unknown and understudied. MG53, a cell membrane repair protein, has been shown to reduce brain lesion size following TBI. In this study, we aimed to establish a large animal model of post-TBI MOD, determine MG53's role in renal protection following TBI, and explore a mechanistic link between endothelial cell dysfunction and post-TBI MOD.

METHODS: Female Yorkshire swine (n = 5/group) were subjected to controlled cortical impact TBI and randomized to receive (1) MG53 protein therapy or (2) normal saline (control). Biomarkers of acute kidney injury were compared between the groups. Kidneys were analyzed for histologic evidence of acute injury. Top-down proteomics were performed on swine plasma at various times post-TBI.

RESULTS: Control animals had a significant increase in creatinine from baseline by 6 hours post-TBI ( p = 0.007), which was attenuated in the MG53-treated animals ( p = 0.089). Control animals had a significant increase in plasma NGAL from baseline starting at 4 hours from baseline ( p = 0.014). Animals treated with MG53 had no change in serum NGAL from baseline ( p = 0.163). Histologic analysis showed protection of proximal tubular epithelial cell damage in animals treated with MG53. Proteoform data showed differential expression of apolipoprotein 1, fibrinogen β, and osteocalcin.

CONCLUSION: Traumatic brain injury can induce distant organ damage, possibly through endothelial cell dysfunction, and treatment with a cell membrane repair protein (MG53) can protect against this injury.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Liggett MR, Wang B, Dawood ZS, et al. Treatment with MG53 ameliorates traumatic brain injury-associated acute kidney injury. J Trauma Acute Care Surg. 2025. PMID: 40523078. doi:10.1097/TA.0000000000004660

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。